Biosciences
Our researchers in have a rich legacy of collaboration with government agencies and industry partners that improve health outcomes and well-being around the world. SRI Biosciences projects range from high-impact, early-stage research to drug co-development with pharmaceutical and biotech companies.
-
SRI International and Exscientia Enter Collaboration to Accelerate Drug Discovery Through Automation and Artificial Intelligence
Companies will combine SynFini and Centaur Chemist platforms to focus on small-molecule oncology target.
-
Better Sleep Through Wearables?
Modern technology could be the key to solving our sleep issues.
-
Iktos and SRI International Announce Collaboration to Combine Artificial Intelligence and Novel Automated Discovery Platform for Accelerated Development of New Anti-Viral Therapies
Researchers will utilize Iktos’ generative modeling AI technology with SRI’s SynFini synthetic chemistry platform to discover new compounds against multiple viruses, including the coronavirus (COVID-19).
-
SRI Introduces Novel Synthetic Chemistry System at SLAS 2020
SRI Biosciences Chief Strategy Officer Nathan Collins, Ph.D., will present an overview of SynFini, the company’s fully automated, end-to-end synthetic-chemistry system.
-
If better sleep is part of your New Year’s resolution, check out this study from SRI researchers about the usefulness of a fitness watch for sleep tracking
-
Research Shows Fitness Watch Can Accurately Track Sleep Patterns
Results from first study comparing consumer sleep tracker against research-grade tracker over two weeks in home environment published in Journal of Sleep.
-
The brain may actively forget during dream sleep
In this study, scientists looked at neighboring cells that produce melanin concentrating hormone, a molecule known to be involved in the control of both sleep and appetite.